investorscraft@gmail.com

Intrinsic ValueUniversal Health Services, Inc. (0LJL.L)

Previous Close£199.49
Intrinsic Value
Upside potential
Previous Close
£199.49

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2024 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

Universal Health Services, Inc. (UHS) is a diversified healthcare provider operating acute care hospitals and behavioral health facilities across the U.S., U.K., and Puerto Rico. The company generates revenue through two primary segments: Acute Care Hospital Services, offering surgical, diagnostic, and emergency care, and Behavioral Health Care Services, addressing mental health and addiction treatment. With 363 inpatient and 40 outpatient facilities, UHS holds a strong regional presence, leveraging economies of scale in purchasing and administrative efficiencies. The company competes in the fragmented healthcare services sector, differentiating itself through integrated care models and a dual focus on physical and behavioral health. Its scale allows for cost-effective operations, while its geographic diversification mitigates regional market risks. UHS also provides ancillary services like insurance and management support, enhancing its value proposition to patients and payers.

Revenue Profitability And Efficiency

UHS reported FY2024 revenue of $15.8 billion, with net income of $1.14 billion, reflecting a 7.2% net margin. Operating cash flow stood at $2.07 billion, underscoring robust cash generation. Capital expenditures of $943.8 million indicate ongoing investments in facility upgrades and expansions. The company’s operational efficiency is evident in its ability to convert revenue into cash flow, supporting both growth and debt management.

Earnings Power And Capital Efficiency

Diluted EPS of $16.82 highlights UHS’s earnings strength, driven by its dual-segment model. The company’s capital efficiency is supported by its scalable infrastructure, which optimizes fixed costs across its extensive network. Operating cash flow coverage of capital expenditures (2.2x) demonstrates sustainable reinvestment capacity, while its asset-light management services segment contributes to higher-margin revenue streams.

Balance Sheet And Financial Health

UHS maintains a leveraged balance sheet with total debt of $4.96 billion against cash reserves of $126 million. The debt load is manageable given its stable cash flows, but interest coverage remains a focus. The company’s liquidity position is adequate, with operating cash flow sufficient to service obligations and fund growth initiatives without immediate refinancing needs.

Growth Trends And Dividend Policy

UHS has consistently grown through organic expansions and acquisitions, particularly in behavioral health, a high-demand sector. The company pays a modest dividend ($0.80 per share), prioritizing reinvestment over shareholder returns. Growth trends are supported by demographic tailwinds, including aging populations and increasing mental health awareness, though regulatory pressures pose risks.

Valuation And Market Expectations

With a market cap of $12.1 billion and a beta of 1.3, UHS trades at a premium reflective of its defensive healthcare exposure and growth potential. Investors likely price in steady demand for its services, though reimbursement risks and labor costs could weigh on margins. The stock’s volatility aligns with broader market sensitivity.

Strategic Advantages And Outlook

UHS benefits from its diversified footprint, dual-segment resilience, and operational scale. Near-term challenges include labor shortages and regulatory scrutiny, but long-term demand for healthcare services remains robust. Strategic acquisitions and cost controls position the company to capitalize on industry consolidation and shifting care delivery models.

Sources

Company filings, Bloomberg

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2025202620272028202920302031203220332034203520362037203820392040204120422043204420452046204720482049

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount